Pre-order Enquiry
Request Free Sample
Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Research Report 2022
SKU ID : QYR-21348589 | Publishing Date : 18-Jul-2022 | No. of pages : 86
Detailed TOC of Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Haemophilia A
1.2.3 Haemophilia B
1.3 Market by Application
1.3.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Perspective (2017-2028)
2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Growth Trends by Region
2.2.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Region (2017-2022)
2.2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Region (2023-2028)
2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Market Dynamics
2.3.1 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Trends
2.3.2 Hemophilia A and B Recombinant Factor Replacement Therapy Market Drivers
2.3.3 Hemophilia A and B Recombinant Factor Replacement Therapy Market Challenges
2.3.4 Hemophilia A and B Recombinant Factor Replacement Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Revenue
3.1.1 Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Revenue (2017-2022)
3.1.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue
3.4 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Concentration Ratio
3.4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue in 2021
3.5 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players Head office and Area Served
3.6 Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product Solution and Service
3.7 Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemophilia A and B Recombinant Factor Replacement Therapy Breakdown Data by Type
4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Type (2017-2022)
4.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Type (2023-2028)
5 Hemophilia A and B Recombinant Factor Replacement Therapy Breakdown Data by Application
5.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Application (2017-2022)
5.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028)
6.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022)
6.3 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028)
7.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022)
7.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028)
8.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028)
9.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022)
9.3 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2017-2028)
10.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.1.4 Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.2.4 Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
11.2.5 Novo Nordisk Recent Development
11.3 Baxalta
11.3.1 Baxalta Company Detail
11.3.2 Baxalta Business Overview
11.3.3 Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.3.4 Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
11.3.5 Baxalta Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.4.4 Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
11.4.5 Bayer Recent Development
11.5 Biogen
11.5.1 Biogen Company Detail
11.5.2 Biogen Business Overview
11.5.3 Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.5.4 Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
11.5.5 Biogen Recent Development
11.6 CSL Behring
11.6.1 CSL Behring Company Detail
11.6.2 CSL Behring Business Overview
11.6.3 CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.6.4 CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
11.6.5 CSL Behring Recent Development
11.7 Emergent Biosolutions
11.7.1 Emergent Biosolutions Company Detail
11.7.2 Emergent Biosolutions Business Overview
11.7.3 Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.7.4 Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
11.7.5 Emergent Biosolutions Recent Development
11.8 Spark therapeutics
11.8.1 Spark therapeutics Company Detail
11.8.2 Spark therapeutics Business Overview
11.8.3 Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.8.4 Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
11.8.5 Spark therapeutics Recent Development
11.9 Uniqure
11.9.1 Uniqure Company Detail
11.9.2 Uniqure Business Overview
11.9.3 Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.9.4 Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
11.9.5 Uniqure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Research Report 2022
List of TablesTable 1. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Haemophilia A
Table 3. Key Players of Haemophilia B
Table 4. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region (2017-2022)
Table 8. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region (2023-2028)
Table 10. Hemophilia A and B Recombinant Factor Replacement Therapy Market Trends
Table 11. Hemophilia A and B Recombinant Factor Replacement Therapy Market Drivers
Table 12. Hemophilia A and B Recombinant Factor Replacement Therapy Market Challenges
Table 13. Hemophilia A and B Recombinant Factor Replacement Therapy Market Restraints
Table 14. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Players (2017-2022)
Table 16. Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy as of 2021)
Table 17. Ranking of Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product Solution and Service
Table 21. Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Application (2017-2022)
Table 29. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Application (2023-2028)
Table 31. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Pfizer Company Detail
Table 42. Pfizer Business Overview
Table 43. Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 44. Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million)
Table 45. Pfizer Recent Development
Table 46. Novo Nordisk Company Detail
Table 47. Novo Nordisk Business Overview
Table 48. Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 49. Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million)
Table 50. Novo Nordisk Recent Development
Table 51. Baxalta Company Detail
Table 52. Baxalta Business Overview
Table 53. Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 54. Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million)
Table 55. Baxalta Recent Development
Table 56. Bayer Company Detail
Table 57. Bayer Business Overview
Table 58. Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 59. Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million)
Table 60. Bayer Recent Development
Table 61. Biogen Company Detail
Table 62. Biogen Business Overview
Table 63. Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 64. Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million)
Table 65. Biogen Recent Development
Table 66. CSL Behring Company Detail
Table 67. CSL Behring Business Overview
Table 68. CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 69. CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million)
Table 70. CSL Behring Recent Development
Table 71. Emergent Biosolutions Company Detail
Table 72. Emergent Biosolutions Business Overview
Table 73. Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 74. Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million)
Table 75. Emergent Biosolutions Recent Development
Table 76. Spark therapeutics Company Detail
Table 77. Spark therapeutics Business Overview
Table 78. Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 79. Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million)
Table 80. Spark therapeutics Recent Development
Table 81. Uniqure Company Detail
Table 82. Uniqure Business Overview
Table 83. Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 84. Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022) & (US$ Million)
Table 85. Uniqure Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type: 2021 VS 2028
Figure 2. Haemophilia A Features
Figure 3. Haemophilia B Features
Figure 4. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application in 2021 & 2028
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Hemophilia A and B Recombinant Factor Replacement Therapy Report Years Considered
Figure 9. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region: 2021 VS 2028
Figure 12. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Players in 2021
Figure 13. Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue in 2021
Figure 15. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2017-2028)
Figure 17. United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2017-2028)
Figure 21. Germany Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region (2017-2028)
Figure 29. China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2017-2028)
Figure 37. Mexico Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2017-2028)
Figure 41. Turkey Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Pfizer Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
Figure 44. Novo Nordisk Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
Figure 45. Baxalta Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
Figure 46. Bayer Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
Figure 47. Biogen Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
Figure 48. CSL Behring Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
Figure 49. Emergent Biosolutions Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
Figure 50. Spark therapeutics Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
Figure 51. Uniqure Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Keyplayers in Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Research Report 2022
PfizerNovo Nordisk
Baxalta
Bayer
Biogen
CSL Behring
Emergent Biosolutions
Spark therapeutics
Uniqure
Request Sample
Request Discount
